No aggravation of renal injury in apolipoprotein E knockout mice (ApoE-/-) after subtotal nephrectomy

Nephrology Dialysis Transplantation

Volumn 19, Issue 3, 2004, Pages 566-573

  Buzello, Moriz ^a   Haas, Christian Stefan ^b   Hauptmann, Frank ^a   Gross, Marie Luise ^a   Faulhaber, Jörg ^c   Schultze Mosgau, Stefan ^b   Ehmke, Heimo ^c   Ritz, Eberhard ^a   Amann, Kerstin ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ApoE knockout mouse; Dyslipidaemia; Glomerulosclerosis; Progression of renal failure; Subtotal nephrectomy

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; FOOD INTAKE; GLOMERULOSCLEROSIS; HEART RATE; HISTOPATHOLOGY; HYPERLIPOPROTEINEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PERFUSION; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; UNINEPHRECTOMY;

ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRECTOMY; TIME FACTORS;

EID: 1342285002     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg578     Document Type: Article

References (32)

1. Keane WF, Kasiske BL, O'Donell MP. The role of lipids in progressive glomerular disease. Adv Exp Med Biol 1987; 223: 81-87
2. Samuelsson O, Attman PO, Knight-Gibson C et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 1998; 9: 1482-1488
3. Scheuer H, Gwinner W, Hohlbach, J et al. Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol 2000; 278: F63-F74
4. Song H, Li X, Zhu C, Wie M. Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by lipid-rich diet. Pediatr Nephrol 2000; 15: 196-200
5. Thorngate FE, Rudel RL, Walzer RL, Williams DL. Low level of extrahepatic nonmacrophage apoE inhibits atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 1939-1945
6. Binder CJ, Weiher H, Exner M, Kerjaschki D. Glomerular overproduction of oxygen radicals in Mpv17 gen inactivated mice causes podocyte foot process flattening and proteinuria: a model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am J Pathol 1999; 154: 1067-1075
7. Coimbra TM, Janssen U, Gröne HJ et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182
8. Lambert G, Sakai N, Vaisman BL et al. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem 2001; 276: 15090-15098
9. Ingram AJ, Parbtani A, Clark WF et al. Dietary alteration of dihomogamma-linolenic acid/arachidonic acid ratio in a rat 5/6-renal-ablation model. J Am Soc Nephrol 1996; 7: 1024-1031
10. McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int 2000; 58: 2341-2350
11. Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 1997; 51: 1151-1159
12. Vazquez-Perez S, Aragoncillo P, de Las Heras N et al. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrol Dial Transplant 2001; 16 [Suppl 1]: 40-44
13. Moghadasian MH, McManus BM, Nguyen LB et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J 2001; 15: 2623-2630
14. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923
15. Wen M, Segerer S, Dantas M et al. Renal injury in apolipoprotein E-deficient mice. Lab Invest 2002; 82: 999-1006
16. Bruneval P, Bariety J, Belair MF, Mandet C, Heudes D, Nicoletti A. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant 2002; 17: 2099-2107
17. Buzello M, Törnig J, Faulhaber J, Ehmke H, Ritz E, Amann K. The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14: 311-316
18. 2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 1998; 53: 1696-1705
19. Amann K, Kronenberg G, Gehlen F et al. Cardiac remodelling in experimental renal failure-an immunhistochemical study. Nephrol Dial Transplant 1998; 13: 1958-1966
20. Dono R, Texido G, Dussel R, Ehmke H, Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 1998; 17: 4213-4225
21. Amann K, Nichols C, Törnig J, Schwarz U, Zeier M, Mall G, Ritz E. Effect of ramipril, nifedipine and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Nephrol Dial Transplant 1996; 11: 1003-1011
22. Weibel ER. Practical methods of biological morphometry. In: Stereological Methods. Academic Press, New York: 1979
23. Amann K, Koch A, Hofstetter J et al. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 2001; 60: 1309-1323
24. Amann K, Rump LC, Simonaviciene A et al. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomised rats. J Am Soc Nephrol 2000; 11: 1469-1478
25. Haas CS, Amann K, Schittny J, Blaser B, Müller U, Hartner A. Glomerular and renal vascular structural changes in alpha8 integrin-deficient mice. J Am Soc Nephrol 2003; 14: 2288-2296
26. Gross ML, El-Shakmak A, Szabo A et al. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 2003; 4: 856-868
27. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-angiotensin system in human tissues: quantitative analysis by the polymerase chain reaction. J Clin Invest 1993; 91: 2058-2064
28. Zheng F, Plati AR, Potier M et al. Resistance to glomerulosclerosis in b6 mice disappears after menopause. Am J Pathol 2003; 162: 1339-1348
29. O'Donnell MP, Kasiske BL, Kim Y, Schmitz PG, Keane WF. Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis 1993; 22: 83-89
30. Nabokov A, Amann K, Gassmann P, Schwarz U, Orth SR, Ritz E. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity. Nephrol Dial Transplant 1998; 13: 173-176
31. Romero R, Higueruelo S, Vaquero M, Biosca C, Martinez-Ocana JC, Pastor C. Effects of polyunsaturated fatty acids on rat glomerulosclerosis induced by hypercholesterolaemic diet. Res Exp Med (Berl) 1998; 198: 1-10
32. Bro S, Bentzon JF, Falk E, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein-E deficient mice. J Am Soc Nephrol 2003; 14: 2466-2474